Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
5
×
life sciences
merck
5
×
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
europe top stories
indiana blog main
indiana top stories
national
national top stories
new york top stories
pfizer
philadelphia blog main
philadelphia top stories
raleigh-durham top stories
san diego top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amag pharmaceuticals
arch venture partners
astrazeneca
cancer
What
bio
roundup
amid
bombast
buy
cancer
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
acquisitions
adding
aims
alliance
biggest
bristol
build
calls
ceo
changing
color
company
company’s
crispr
daniel
days
deal
debut
Language
unset
5
×
Current search:
merck
×
deals
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal